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ABSTRACT 
A new, simple, precise, rapid and selective high-performance thin-layer chromatographic (HPTLC) method for 
the simultaneous quantification of Metronidazole (MTZ) and Miconazole nitrate (MCZ) in gel has been 
developed. It was performed on silica gel 60 GF254 Thin Layer Chromatographic plates using mobile phase 
comprising of Toluene: Chloroform: Methanol (3.0:2.0:0.6 v/v) and the detection was carried out at 240 nm 
using densitometer. The retention factors of MTZ and MCZ were 0.34 and 0.55 respectively. Calibration curves 
were linear in the range of 300-700 ng/spot of MTZ and 600-1400 ng/spot of MCZ both by height and by area. 
The percent recovery of the drugs from gel carried out by standard addition method was found to be 
100.13±1.59 (by height) and 98.92±0.76 (by area) for MTZ and 99.49±1.58 (by height) and 99.63±1.46 (by 
area) for MCZ indicative of accuracy and precision of simultaneous determination of MTZ and MCZ nitrate. 
 




Metronidazole (MTZ), or 2-(2-methyl-5-nitro-1H-
imidazol-1-yl)-ethanol, is active against a wide variety of 
anaerobic parasites and anaerobic bacteria. Miconazole 
nitrate (MCZ), or 1-[2,4-dichloro-β-[(2, 4-dichloro-
benzyl)oxy] phenethyl] imidazole, is an anti bacterial of 
the class of imidazole. The two drugs are used in 
association in the treatment as antiprotozoal and 
antibacterial. 
 
Various methods are available for the quantitative 
determination of MTZ and MCZ nitrate individually or in 
combination with other drugs, such as gas 
chromatography (Kublin  and Kanjewaska, 1996), 
voltametry  (Yao et al., 1998) HPLC (Raj et al., 1997, 
Argekar and Shah, 1998, Nadkarni et al., 1997, Bhoir et 
al., 1997, Bari et al., 1998 ) and spectrophotometry  
(Parimoo et al., 1996, Amin, 1997, Mohamed et al., 1996, 
Paliwal et al., 1998, Paliwal et al., 1998, Wrobel et al., 
1999, Basu et al., 1991, Das et al., 1992 ). 
 
Two methods have been reported for simultaneous 
estimation of MCZ and MTZ. The first one reported 
spectrophotometric (ratio spectra derivative) and RP-LC 
(Erk and Levent, 2001) method for simultaneous 
estimation of the two drugs in ovules. It is very tedious 
and time consuming and needed the HPLC method for 
comparison purpose. The HPLC method reported herein 
does not demonstrate proper resolution of the two drugs, 
which is required for estimation in presence of the 
impurities.  The second is a RP-HPLC (Akay et al., 2002) 
method with UV detection. This method demonstrates 
better resolution of the two drugs. 
Combination dosages containing these two drugs are 
available everywhere (e.g., Drez V gel manufactured by 
Stedman India Ltd., etc.). However there is no method for  
simultaneous estimation of these two drugs by high-
performance thin-layer chromatography (HPTLC). 
HPTLC is more effective technique for the simultaneous 
determination in single samples in routine analysis 
(Agrekar and Powar, 2000). The aim of present study is to 
develop a simple HPTLC method for simultaneous 
determination and quantitation of MCZ and MTZ in gels, 
using Toluene: Chloroform: Methanol (3.0:2.0:0.6 v/v) as 
mobile phase on silica gel 60 GF254 TLC plates (Merck). 
Quantitative estimation was accomplished by 
densitometric scanning with UV detector at 240 nm 
wavelength. The method was successfully applied to the 




Instrumentation, solvents and chemicals 
A Camag Linomat IV sample applicator, a Camag TLC 
Scanner III controlled by Cats 4.0 version software and a 
Camag twin trough chamber were used.  Merck TLC plate 
(Art. No.1.05554.0007) coated with silica gel 60 GF254 
(200 µm thickness) on aluminium sheets were used as the 
stationary phase. 
 
Pharmaceutical grade of miconazole nitrate was kindly 
supplied as gift sample by M/s Wokhardt India Ltd., 
Aurangabad and metronidazole by Nestor Pharma-
ceuticals Ltd., Faridabad, India.  All chemicals and 
reagents were of HPLC grade and were purchased from 
Merck Chemicals, India. Drez-V (Gel) (Stedman, India) 
labeled to contain MTZ 1% and MCZ 2% was purchased 
locally. 
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Chromatographic conditions 
Stationary phase – Merck silica gel 60 GF254 TLC 
precoated aluminium plates, 200 µm layer thickness, 
Mobile phase- Toluene: Chloroform: Methanol 
(3.0:2.0:0.6v/v), Chamber saturation time - 10 minute, 
Sample application – 4 mm band, Separation technique - 
Ascending, Temperature - 25 ± 2ºC, Relative humidity - 
60% ± 5, Migration distance – 70 mm, Scanning mode - 
Absorbance/reflectance, Detection wavelength - 240nm, 
Band Width- 4 mm, Slit dimension- 3×0.45 mm, 
Scanning speed- 10 mm/s, Monochromator bandwidth- 20 
mm.  
 
Standard solutions   
Mixed stock standard solution containing 1.0 mg/ml MTZ 
and 2.0 mg/ml MCZ was prepared by dissolving in 
methanol.  Working standard solution were prepared by 
further dilution of stock standard with methanol to give 
final concentration of MTZ, 100 µg/ml and MCZ 200 
µg/ml. This solution was used as working standard for 
analysis of all the samples. 
 
Sample preparation 
An accurately weighed quantity of cream equivalent to 
about 2 mg of Miconazole nitrate (also equivalent to 
about 1 mg of metronidazole) was weighed in to 10.0 ml 
volumetric flask and was dissolved in methanol with 
shaking for 25 min. The volume was made up to the mark 
with methanol. The solution was centrifuged and 
supernatant was used as sample solution. 
 
Calibration procedure  
The working standard solution was applied on the TLC 
plate in the range of 1-10 µl. The plate was developed and 
scanned as mentioned in chromatographic conditions. 
 
Peak height and peak area were recorded for each drug 
concentration and the instrument displayed the linear 
regression curve for concentration vs. peak height/area for 
both the drugs. 
 
Assay procedure 
Two bands of the working standard solution and eight 
bands of sample solution 5 µl each were applied on TLC 
plates to give concentration of about 1000 ng/spot for 
MCZ and 500 ng/spot for MTZ respectively. The plate 
was developed and scanned under the previously 
mentioned optimized chromatographic conditions. The 
amount of MCZ and MTZ present in the applied volume 
of sample was displayed by the instrument by comparing 
peak height and area of the sample with that of standard.  
 
Method validation   
Precision 
Precision of the method was determined by inter-day, 
intra-day and analyst to analyst variation. System 
reproducibility was determined by five replicate 
applications and five times measurement of a laboratory 
mixture at the analytical concentration. This was 
performed by preparing laboratory mixtures of 
miconazole nitrate and metronidazole in the ratio 
mentioned in marketed formulations.  The reproducibility 
of sample application by measurement of concentration 
with respect to height and area for active compounds were 
expressed in terms of SD and %RSD.  
 
Recovery studies 
Recovery studies were carried out by applying the method 
to drug sample to which the known amount of miconazole 
nitrate and metronidazole has been spiked (standard 
addition method). Accurately weighed quantities of cream 
equivalent to about 1.4 mg of MCZ (equivalent to about 
70% of the prescribed sample weight as per the proposed 
method) were transferred to five different 10.0 ml 
volumetric flasks and 1 to 5 ml of mixed standard solution 
(conc: MCZ-0.201 mg/ml and MTZ 0.101 mg/ml) were 
added to them followed by methanol.  The flasks were 
shaken for 30 min and the volumes were made up to the 
mark with methanol (The drug content in different flasks 
represents 80-120% of labeled claims with constant 
amount of excipients). The solutions were then 
centrifuged and the supernatant was used as sample 
solution.  
 
Two bands of standard and eight bands of each sample 
solutions (5 µl each) were applied on TLC plate and the 
plates were developed and scanned under the optimized 
chromatographic conditions.  
 
Specificity studies 
Sample solutions were prepared by exposing an 
accurately weighed quantity of cream equivalent to 2 mg 
of miconazole nitrate and 1 mg of metronidazole to 
various stress conditions, like at 50°C after addition of 1.0 
ml of 0.1 N HCl (acid), at 50°C after addition of 1.0 ml of 
0.1 N NaOH (alkali), at 50°C after addition of 1.0 ml of 
3.0% H2O2 (oxide), at 60°C and in UV-cabinet at 265 nm 
for 24 hr.  The sample solutions were then analyzed by 
the proposed method. 
 
RESULT AND DISCUSSION 
 
Optimization of procedure 
Since both MCZ and MTZ dissolve better in methanol, it 
was used to prepare standard solutions as well as for 
extraction from gel. 
 
Various blends of solvent systems in varying proportions 
were tried as mobile phase. However, mobile phase 
consisting of toluene: chloroform: methanol (3.0:2.0:0.6 
v/v/v), gave good resolution, dense and compact spots 
along with minimum tailing and Rf values of 0.34 and 
0.55 for MTZ and MCZ respectively. The selection of 
wavelength was based on UV absorbance by both the 
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drugs with due consideration to their ratio in the 
formulations. Both peaks were symmetrical in nature and 
no tailing was observed when scanned at 240 nm (fig. 1). 
The chamber saturation time with the mobile phase was 
10 min at room temperature. 
 
 
Fig. 1: Densitogram of Metronidazole (500 ng/spot); peak 
1 (Rf: 0.34±0.02) and Miconazole nitrate (1000ng/spot); 
peak 2 (Rf: 0.55±0.02) in standard (A) and sample 
solution (B). 
Linearity 
MTZ showed good correlation coefficient in the 
concentration range of 300-700 ng/spot (r = 0.9971 and 
0.9996 by height and area respectively) and MCZ in the 
range of 600-1400 ng/spot (r=0.9919 and 0.9954 by 
height and area respectively) (table 1). In case of linear 
detector response both the drugs in varying concentration 
show better linear relationship when plotted with 
concentration vs peak height/peak area (fig. 2). Apart 
from correlation coefficient value the intercept value was 
not more than 2% of the response observed at 100% 
concentration in both the cases and hence, single point 
calibration was used. 
 
Precision 
The reproducibility of sample application by 
measurement of concentration with respect to height and 
area for active compounds were expressed in terms of SD 
and %RSD and the results are shown in table 2. The 
%RSD values depicted in table 3 showed that the 
proposed method provide acceptable inter-day, intra-day 
and analyst to analyst variation of MTZ and MCZ.  
 
Recovery studies 
The proposed method when used for extraction and 
subsequent estimation of miconazole nitrate and 
metronidazole from pharmaceutical dosage form after 
spiking with additional drug afforded recovery in the 
range of 98.92-100.13% and mean recovery for 
miconazole nitrate and metronidazole from marketed 
formulation are listed in table 4. The results of recovery 
study indicate that the common excipients present in gel 
formulation do not interfere with estimation of the two 
drugs.  
 
Table 1: Linear regression data for calibration curves-HPTLC (n=3)  
 






















Table 2: Results of system reproducibility-HPTLC (n=5) 
 
Metronidazole Miconazole nitrate Parameter Height Area Height Area 
















*Each mean %estimated is a mean of five observations 
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Specificity 
The specificity of the method evaluated on the basis of 
forced degradation by exposing the sample to various 
stress conditions has shown reasonable specificity of the 
proposed method.  In case of estimation of metronidazole, 
the results of the sample treated with a base were much on 
lower side without additional peaks, indicating that 
sample has undergone degradation and the degradation 
product staying at starting point or transformed to non-
chromophoric group which does not absorb at wavelength 
of estimation. In addition to this the results were also low 
by about 5-7 % in samples treated with hydrogen 
peroxide and UV radiations compared to the normal 
samples. In case of miconazole nitrate the sample of UV 
irradiated and hydrogen peroxide treated sample the 
results were low by about 5-10%. In case of all other 
treated samples the results of estimation of metronidazole 
and miconazole nitrate were close to normal samples 
indicating that, there is no degradation (table 5). 
 
Analysis of the marketed formulations 
The peaks at Rf 0.34 (MTZ) and 0.55 (MCZ) were 
observed in the densitograms (fig. 1) of the drug samples 
extracted from gel.  There was no interference from the 
common excipient present in cream. The assay values for 
both the drugs in formulation suggest that degradation of 
metronidazole and miconazole nitrate had not occurred in 
the marketed formulations that were analyzed by this 
method as shown in table 6. The %RSD value indicated 
the suitability of this method for routine estimation of 
metronidazole and miconazole nitrate in pharmaceutical 
dosage forms.  
Table 3: Inter-day, intra-day and analyst to analyst precision studies  
 
Metronidazole Miconazole nitrate Parameter Height Area Height Area 
Inter- Day 



















Intra-day     
Mean %estimated* ±S.D. 
% R.S.D.   

















Analyst to Analyst 
Mean %estimated* ±S.D. 
% R.S.D.   


















*Each mean %estimated is a mean of five observations 
 
Table 4: Result of Recovery Study (n=5) 
 
Metronidazole Miconazole nitrate Parameter Height Area Height Area 
Cream 




















*Each mean %recovery is a mean of five observations 
 
Table 5: Results of specificity study 
 
Metronidazole  
(Mean % estimated*) 
Miconazole nitrate 
(Mean % estimated*) Condition 
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CONCLUSION 
 
The method was developed on HPTLC to estimate the 
two drugs simultaneously in formulation, for the first time 
in order to analyze more samples in less time. The 
proposed method is easy to perform, precise, accurate, 
rapid and reasonably specific and rugged. The whole 
procedure may be extended to pharmaceutical 
preparations and other applications on the same drug for 
routine screening. The method was further validated and 
the results were found to be concurrent and comparable to 
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Fig. 2: Linear regression curves of miconazole nitrate by height (A) and area (B) and metronidazole by height (C) 
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